|
NL62140C
(enExample)
|
1942-12-16 |
|
|
|
|
DE2104179C3
(de)
|
1971-01-29 |
1980-10-02 |
Knoll Ag, 6700 Ludwigshafen |
exo-2-Phenyl-bicyclo- [2,2,1] -heptan-2- (N-methylpiperidol-4)-carbonsäureester und dessen Salze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
|
|
FR2155927A1
(en)
|
1971-10-15 |
1973-05-25 |
Synthelabo |
1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
|
|
FR2168881A1
(en)
|
1972-01-25 |
1973-09-07 |
Synthelabo |
Tropanol 1-phenylcycloalkane carboxylic ester salts - spasmolytics and cholinergics
|
|
FR2208649A1
(en)
|
1972-12-01 |
1974-06-28 |
Synthelabo |
1-(2-Thienyl)cycloalkane carboxylic ester salts - with spasmolytic and anticholinergic activity
|
|
GB8334494D0
(en)
|
1983-12-24 |
1984-02-01 |
Tanabe Seiyaku Co |
Carbostyril derivatives
|
|
GR1001529B
(el)
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
|
|
SE9003057D0
(sv)
|
1990-09-26 |
1990-09-26 |
Astra Ab |
New process
|
|
TR199900185T2
(xx)
|
1996-07-29 |
1999-04-21 |
Pharmacia & Upjohn Ab |
Arisikloalkan karboksilik esterler, bunlar�n kullan�m�, farmakolojik bile�imler.
|
|
EP0937041B1
(de)
|
1996-11-11 |
2003-04-23 |
Christian R. Noe |
Verwendung eines pharmazeutisch geeigneten Salzes von (3R,2'R)-3-[(Cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium zur Herstellung eines Arzneimittels
|
|
US6613795B2
(en)
|
1996-11-11 |
2003-09-02 |
Christian Noe |
Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
CN1250545C
(zh)
|
2000-12-28 |
2006-04-12 |
阿尔米雷尔普罗迪斯制药有限公司 |
新的奎宁环衍生物类及含有这类衍生物的药物组合物
|
|
WO2002076933A1
(en)
|
2001-03-22 |
2002-10-03 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
JP2004532874A
(ja)
|
2001-04-03 |
2004-10-28 |
アリックス セラピューティクス |
抗コリン作用性化合物および使用法
|
|
WO2002088167A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
US20030229058A1
(en)
|
2001-11-13 |
2003-12-11 |
Moran Edmund J. |
Aryl aniline beta2 adrenergic receptor agonists
|
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
|
DE10216333A1
(de)
|
2002-04-13 |
2003-10-30 |
Boehringer Ingelheim Pharma |
Neue Carbonsäureester mit anticholonerger Wirksamkeit, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
|
ES2302938T3
(es)
|
2002-10-11 |
2008-08-01 |
Pfizer Inc. |
Derivados de indol como agonistas beta-2.
|
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
|
AR044134A1
(es)
*
|
2003-05-02 |
2005-08-24 |
Novartis Ag |
Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
|
|
AR044851A1
(es)
|
2003-06-24 |
2005-10-05 |
Novartis Ag |
Compuestos heterociclicos, antagonistas del receptor m3 muscarinico
|
|
AU2004285592B2
(en)
|
2003-11-03 |
2010-02-18 |
Norton Healthcare, Ltd. |
Soft steroid compositions for use in dry powder inhalers
|
|
JPWO2006025324A1
(ja)
|
2004-08-30 |
2008-05-08 |
小野薬品工業株式会社 |
トロパン化合物およびそれらを有効成分として含有する医薬組成物
|
|
WO2006035303A1
(en)
|
2004-09-29 |
2006-04-06 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
CA2584413A1
(en)
|
2004-10-29 |
2006-05-04 |
Astrazeneca Ab |
Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
|
|
GB0424284D0
(en)
*
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
|
GB0428416D0
(en)
|
2004-12-24 |
2005-02-02 |
Novartis Ag |
Organic compounds
|
|
TW200722418A
(en)
|
2005-04-20 |
2007-06-16 |
Astrazeneca Ab |
Novel compounds
|
|
US20080194632A1
(en)
|
2005-08-01 |
2008-08-14 |
Astrazeneca Ab |
Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory Diseases
|
|
TW200738635A
(en)
|
2005-08-02 |
2007-10-16 |
Astrazeneca Ab |
New salt
|
|
EP1924553A1
(en)
|
2005-08-08 |
2008-05-28 |
Argenta Discovery Limited |
Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
|
|
GB0516313D0
(en)
|
2005-08-08 |
2005-09-14 |
Argenta Discovery Ltd |
Azole derivatives and their uses
|
|
TW200738658A
(en)
|
2005-08-09 |
2007-10-16 |
Astrazeneca Ab |
Novel compounds
|
|
TW200738659A
(en)
|
2005-08-29 |
2007-10-16 |
Astrazeneca Ab |
Novel compounds
|
|
JP2009519310A
(ja)
|
2005-12-16 |
2009-05-14 |
アージェンタ ディスカバリー リミテッド |
環状アミン誘導体およびそれらの使用
|
|
WO2007123465A1
(en)
|
2006-04-24 |
2007-11-01 |
Astrazeneca Ab |
New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
|
|
TW200821316A
(en)
|
2006-07-19 |
2008-05-16 |
Astrazeneca Ab |
Novel compounds 243
|
|
WO2008017827A2
(en)
|
2006-08-08 |
2008-02-14 |
Argenta Discovery Limited |
Azole and thiazole derivatives and their uses
|
|
GB0702384D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
Chemical compounds
|
|
JP2010501533A
(ja)
|
2006-08-21 |
2010-01-21 |
アージェンタ ディスカバリー リミテッド |
Ｍ３レセプター調節物質として有用な窒素含有複素環化合物
|
|
EP1894568A1
(en)
|
2006-08-31 |
2008-03-05 |
Novartis AG |
Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
|
|
TW200825084A
(en)
|
2006-11-14 |
2008-06-16 |
Astrazeneca Ab |
New compounds 521
|
|
WO2008059239A1
(en)
|
2006-11-14 |
2008-05-22 |
Astrazeneca Ab |
Novel compounds 514
|
|
WO2008075006A1
(en)
|
2006-12-19 |
2008-06-26 |
Astrazeneca Ab |
Piperldinum compounds for treatment of obstructive pulmonary diseases ( copd)
|
|
WO2008075005A1
(en)
|
2006-12-19 |
2008-06-26 |
Astrazeneca Ab |
Quinuclidinol derivatives as muscarinic receptor antagonists
|
|
TW200833670A
(en)
|
2006-12-20 |
2008-08-16 |
Astrazeneca Ab |
Novel compounds 569
|
|
WO2008096093A1
(en)
|
2007-02-06 |
2008-08-14 |
Argenta Discovery Ltd. |
Oxazole and thiazole derivatives and their uses
|
|
WO2008096094A1
(en)
|
2007-02-06 |
2008-08-14 |
Argenta Discovery Ltd. |
Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators
|
|
GB0702382D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
New salt
|
|
GB0702385D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
New combination
|
|
GB0702413D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
New chemical compounds
|
|
BRPI0807004A2
(pt)
|
2007-02-07 |
2014-04-15 |
Argenta Discovery Ltd |
Sal
|
|
GB0702416D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
New combination
|
|
GB0702414D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
Oxazole and thiazole derivatives and their uses 2
|
|
WO2008096129A1
(en)
|
2007-02-07 |
2008-08-14 |
Argenta Discovery Ltd |
Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors
|
|
GB0702456D0
(en)
|
2007-02-08 |
2007-03-21 |
Astrazeneca Ab |
New combination
|
|
GB0702457D0
(en)
|
2007-02-08 |
2007-03-21 |
Astrazeneca Ab |
New combination 666
|
|
TW200843759A
(en)
|
2007-02-15 |
2008-11-16 |
Argenta Discovery Ltd |
Compounds and their use II
|
|
GB0704000D0
(en)
|
2007-03-01 |
2007-04-11 |
Astrazeneca Ab |
Salts 670
|
|
WO2008149110A1
(en)
|
2007-06-08 |
2008-12-11 |
Argenta Discovery Limited |
Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated
|
|
WO2008149053A1
(en)
|
2007-06-08 |
2008-12-11 |
Argenta Discovery Ltd. |
Bicycl0 [2. 2. 1] he pt- 2-ylamine derivates and their use
|
|
WO2009098453A1
(en)
|
2008-02-06 |
2009-08-13 |
Astrazeneca Ab |
Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists
|
|
KR101273200B1
(ko)
|
2008-02-06 |
2013-06-17 |
펄마젠 쎄라퓨틱스 (시너지) 리미티드 |
화합물
|
|
WO2009098455A1
(en)
|
2008-02-06 |
2009-08-13 |
Astrazeneca Ab |
2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease
|
|
CN102908624A
(zh)
|
2008-05-13 |
2013-02-06 |
阿斯利康(瑞典)有限公司 |
包含毒蕈碱性受体拮抗剂和β2-肾上腺素受体激动剂的药物产品
|
|
GB0808709D0
(en)
|
2008-05-13 |
2008-06-18 |
Astrazeneca Ab |
New combination 295
|
|
GB0808708D0
(en)
|
2008-05-13 |
2008-06-18 |
Astrazeneca Ab |
New compounds 274
|
|
GB0808707D0
(en)
|
2008-05-13 |
2008-06-18 |
Argenta Discovery Ltd |
New compounds 275
|
|
NZ589091A
(en)
|
2008-05-13 |
2011-07-29 |
Astrazeneca Ab |
Quinuclidine derivatives as muscarinic m3 receptor antagonists
|
|
GB0811099D0
(en)
|
2008-06-17 |
2008-07-23 |
Astrazeneca Ab |
New combination 376
|
|
WO2009153536A1
(en)
|
2008-06-17 |
2009-12-23 |
Argenta Discovery Limited |
1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists
|
|
GB0811100D0
(en)
|
2008-06-17 |
2008-07-23 |
Astrazeneca Ab |
New combination
|
|
WO2010015792A1
(en)
|
2008-08-06 |
2010-02-11 |
Argenta Discovery Limited |
Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors
|
|
WO2010018352A1
(en)
|
2008-08-12 |
2010-02-18 |
Argenta Discovery Limited |
Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated
|
|
CA2733449A1
(en)
|
2008-08-12 |
2010-02-18 |
Astrazeneca Ab |
2-hydroxy-ethanesulfonate salt
|
|
GB0814729D0
(en)
|
2008-08-12 |
2008-09-17 |
Argenta Discovery Ltd |
New combination
|
|
GB0814728D0
(en)
|
2008-08-12 |
2008-09-17 |
Argenta Discovery Ltd |
New combination
|